Table 1 Clinical and biological characteristics of patients
From: Mineral bone disorder and osteoporosis in hemodialysis patients
Age, mean ± SD yesars | 53.01 ± 14.66 | |
Height, mean ± SD cm | 162.78 ± 9.77 | |
Weight, mean ± SD Kg | 68.33 ± 13.48 | |
Body mass index, mean ± SD kg/m2 | 25.79 ± 4.67 | |
Smoking (n (%)) | 50 (55.5) | |
Adequate exposure to sunlight (n (%)) | 55 (61) | |
Comorbidities | Diabetes (n (%)) | 38 (42) |
Hypertension (n (%)) | 60 (66) | |
Dyslipidemia | 12 (13) | |
Duration of dialysis, mean ± SD years | 3.94 ± 1.99 | |
Causes of CKD | Diabetic nephropathy (n (%)) | 30 (33.3) |
Vascular nephropathy (n (%)) | 6 (6.6) | |
Glomerulonephritis (n (%)) | 40 (44.5) | |
Amyloidosis (n (%)) | 1 (1.2) | |
Polycystic kidney disease (n (%)) | 4 (4.4) | |
Tubulointerstitial nephropathy (n (%)) | 9 (10) | |
Calcium (2–2.25 mmo/L) | 2.08 ± 0.32 | |
Phosphate (2–2.25 mmo/L) | 1.84 ± 0.57 | |
Albumin (30-45 mmom/L) | 35.45 ± 5.64 | |
Total alkaline phosphatase (60–220 U/L) | 88.35 ± 72.56 | |
PTH (12-65 pgmL) | 425.7 ± 380.8 | |
25 OH-vitamin D (ng/L) | 15.76 ± 11.58 | |
bAP (ng/mL) | 26.84 ± 26.99 | |
CTX (ng/mL) | 2.49 ± 1.51 | |
FGF 23 (pg/mL) | 221.87 ± 248.96 | |